Legal Entity
Insights
Associated Business
Financials
Lookalike companies
FAQ
BIOMERIEUX SINGAPORE
Last Updated: 31 Jan 2025
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.
Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
Country of registration | Singapore |
Registration number | 200801225M |
Local SIC | |
Incorporation date | 16 Jan 2008 |
Company age | 18 years 2 months |
Official entity type | Private Limited Company |
No. of officers | 22 |
Contact
Address:
11 BIOPOLIS WAY, #10-04, HELIOS, Singapore 138667
Phone number:
Access Key Decision Makers
This is the legal entity page of BIOMERIEUX SINGAPORE. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- BIOMÉRIEUXView MoreFrancePioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP
This is the legal entity page of BIOMERIEUX SINGAPORE. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | GRANT THORNTON AUDIT LLP |
Revenue | 11m - 25m |
Financial period end date | 31 Dec 2020 |
Share Capital - Ordinary shares | SGD 110,000 |
Last updated: 31 Jan 2025
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of BIOMERIEUX SINGAPORE?
- Where is BIOMERIEUX SINGAPORE's headquarter?
- What is BIOMERIEUX SINGAPORE's contact number?
- What BIOMERIEUX SINGAPORE's spending power?
- Does BIOMERIEUX SINGAPORE have a presence in the domain it operates in?